![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 11, 2016 6:22:12 AM
what I read in the latest PR was ; Our intent is to launch these strengths after FDA final approval following expiry of the other companies' exclusivity period(s).
while the Keppra PR stated this ; "We are actively exploring the best approach to maximize our commercial returns from this new approval."
I do not think they are trying to find a partner for Seroquel. They are telling us "Our intent is to launch". It would not surprise me if they are going to start using their manufacturing capabilities and manufacture the pills themselves and then sell to whomever on a wholesale basis. Now, that language does not stop a partnership but then leans more to the fact they already have one rather than seeking one, because again, they intend to launch. it doesn't say they are looking at the best approach to maximize returns.
just my observation.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM